AJICAP reagent 1b
AJICAP reagent 1b is a thiophenyl ester-based site-specific conjugation reagent for antibody modification applications. AJICAP reagent 1b is used in HER2-positive gastric cancer-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3027489-02-4
- Formel: C105H143N29O26S4
- Molecular Weight:2355.70
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
AJICAP reagent 1b (2.5 equivalents; 1 h) enables efficient site-specific conjugation of native antibodies at Lys248, producing homogeneous antibody-thiol intermediates with an average PAR of 2.0 and minimal aggregation[1].
AJICAP reagent 1b (2.7 equivalents; 1 h) produces site-specific Lys248 ADCs from trastuzumab and rituximab with high DAR values and low aggregation across various drug-linkers[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Chemical Information
-
CAS. Nr. 3027489-02-4
-
Molecular Weight 2355.70
-
Formel C105H143N29O26S4
-
Sequence
Ac-Arg-Gly-Asn-Cys-Ala-Tyr-His-Lys(4-oxo-4-((3-oxo-3-(phenylthio)propyl)thio)butanoic acid)-Gly-Gln-Leu-Val-Trp-Cys-Thr-Tyr-His-NH2 (disulfide bridge:Cys4-Cys14)
-
Sequence Shortening
Ac-RGNCAYH-Lys(4-oxo-4-((3-oxo-3-(phenylthio)propyl)thio)butanoic acid)-GQLVWCTYH-NH2 (disulfide bridge:Cys4-Cys14)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- AJICAP reagent 1b
- 3027489-02-4
- Biochemical Assay Reagents
- rituximab
- site-specific antibody conjugate production
- Lys248
- trastuzumab
- HER2-positive gastric cancer
- Fc-affinity peptide-guided mechanism
- IgG Fc region
- homogeneous DAR of 2
- thiophenyl ester-based site-specific conjugation reagent
- antibody modification
- Inhibitor
- inhibitor
- inhibit